Women's Awareness of and Responses to Messages about Breast Cancer Overdiagnosis and Overtreatment

Medical Care

Volumn 55, Issue 10, 2017, Pages 879-885

  Nagler, Rebekah H ^a   Franklin Fowler, Erika ^b   Gollust, Sarah E ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b WESLEYAN UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

breast cancer; health communication; mammography screening; overdiagnosis; overtreatment

Indexed keywords

ADULT; ARTICLE; AWARENESS; BREAST CANCER; CANCER SCREENING; DECISION MAKING; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL CARE; MEDICAL INFORMATION; PATIENT HARM; PREDICTIVE VALUE; PRIORITY JOURNAL; AGE; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; FALSE POSITIVE RESULT; HEALTH SERVICE; MIDDLE AGED; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

ADULT; AGE FACTORS; AWARENESS; BREAST NEOPLASMS; DECISION MAKING; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MEDICAL OVERUSE; MIDDLE AGED; SOCIOECONOMIC FACTORS;

EID: 85030611110     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000798     Document Type: Article

References (33)

1. Harris RP, Wilt TJ, Qaseem A. A value framework for cancer screening: Advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162:712-717.
2. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605-613.
3. Morris E, Feig SA, Drexler M, et al. Implications of overdiagnosis: impact on screening mammography practices. Popul Health Manag. 2015;18 (suppl 1):S3-S11.
4. Jørgensen K, Gøtzsche PC, Kalager M, et al. Breast cancer screening in Denmark: A cohort study of tumor size and overdiagnosis. Ann Intern Med. 2017;166:313-323.
5. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001.
6. Nagler RH, Fowler EF, Gollust SE. Covering controversy: what are the implications for womens health? Womens Health Issues. 2015;25:318-321.
7. Elstad EA, Sheridan SL, Lee JG, et al. Have screening harms become newsworthy? News coverage of prostate and colorectal cancer screening since the 2008 USPSTF recommendation changes. J Behav Med. 2014;37:1242-1251.
8. Ghanouni A, Meisel SF, Hersch J, et al. Information on "overdiagnosis" in breast cancer screening on prominent United Kingdom and Australiaoriented health websites. PLoS One. 2016;11:e0152279.
9. Moynihan R, Nickel B, Hersch J, et al. Public opinions about overdiagnosis: A national community survey. PLoS One. 2015;10: e0125165.
10. Ghanouni A, Meisel SF, Renzi C, et al. Survey of public definitions of the term "overdiagnosis" in the UK. BMJ Open. 2016;6:e010723.
11. Van den Bruel A, Jones C, Yang Y, et al. Peoples willingness to accept overdetection in cancer screening: population survey. BMJ. 2015;350: h980.
12. Moynihan R, Nickel B, Hersch J, et al. What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians. BMJ Open. 2015;5:e007436.
13. Waller J, Douglas E, Whitaker KL, et al. Womens responses to information about overdiagnosis in the UK breast cancer screening programme: A qualitative study. BMJ Open. 2013;3:8.
14. Hersch J, Jansen J, Barratt A, et al. Womens views on overdiagnosis in breast cancer screening: A qualitative study. BMJ. 2013;346:13.
15. Yu J, Nagler RH, Fowler EF, et al. Womens awareness and perceived importance of the harms and benefits of mammography screening: results from a 2016 National Survey. JAMA Intern Med. 2017. [Epub ahead of print].
16. Schwartz LM, Woloshin S, Fowler FJ Jr, et al. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71-78.
17. Hersch J, Barratt A, Jansen J, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: A randomised controlled trial. Lancet. 2015;385:1642-1652.
18. Wolfson D, Santa J, Slass L. Engaging physicians and consumers in conversations about treatment overuse and waste: A short history of the choosing wisely campaign. Acad Med. 2014;89:990-995.
19. McCaffery KJ, Jansen J, Scherer LD, et al. Walking the tightrope: communicating overdiagnosis in modern healthcare. BMJ. 2016;352:i348.
20. Gigerenzer G. Full disclosure about cancer screening. BMJ. 2016;352: h6967.
21. Zhao X, Strasser A, Cappella JN, et al. A measure of perceived argument strength: reliability and validity. Commun Methods Meas. 2011;5:48-75.
22. Gollust SE, Cappella JN. Understanding public resistance to messages about health disparities. J Health Commun. 2014;19:493-510.
23. Gollust SE, Niederdeppe J, Barry CL. Framing the consequences of childhood obesity to increase public support for obesity prevention policy. Am J Public Health. 2013;103:e96-e102.
24. Bleakley A, Jordan AB, Hennessy M, et al. Do emotional appeals in public service advertisements influence adolescents intention to reduce consumption of sugar-sweetened beverages? J Health Commun. 2015; 20:938-948.
25. Lee S, Cappella JN, Lerman C, et al. Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs. Nicotine Tob Res. 2011;13:282-290.
26. Wegwarth O, Gigerenzer G. Less is more: overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med. 2013;173:2086-2087.
27. Hoffmann TC, Del Mar C. Clinicians expectations of the benefits and harms of treatments, screening, and tests: A systematic review. JAMA Intern Med. 2017;177:407-419.
28. Petrova D, Garcia-Retamero R, Cokely ET. Understanding the harms and benefits of cancer screening: A model of factors that shape informed decision making. Med Decis Making. 2015;35:847-858.
29. Rosenbaum L. Invisible risks, emotional choices-mammography and medical decision making. N Engl J Med. 2014;371:1549-1552.
30. Hoffmann TC, Del Mar C. Patients expectations of the benefits and harms of treatments, screening, and tests: A systematic review. JAMA Intern Med. 2015;175:274-286.
31. Waller J, Osborne K, Wardle J. Enthusiasm for cancer screening in Great Britain: A general population survey. Br J Cancer. 2015;112:562-566.
32. Schwartz LM, Woloshin S, Sox HC, et al. US womens attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320:1635-1640.
33. Zikmund-Fisher BJ, Couper MP, Fagerlin A. Disparities in patient reports of communications to inform decision making in the DECISIONS survey. Patient Educ Couns. 2012;87:198-205.